CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 46 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 4.42 and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,523,924 | -25.4% | 442,704 | -39.4% | 0.39% | -49.5% |
| Q3 2023 | $4,726,154 | +4.7% | 730,472 | +0.2% | 0.77% | +24.5% |
| Q2 2023 | $4,512,987 | +60.8% | 729,077 | 0.0% | 0.62% | +71.5% |
| Q1 2023 | $2,806,946 | +23.4% | 729,077 | -0.7% | 0.36% | +3.7% |
| Q4 2022 | $2,275,171 | -22.6% | 733,926 | +0.3% | 0.35% | -43.7% |
| Q3 2022 | $2,941,000 | -20.3% | 731,521 | -3.5% | 0.62% | -34.3% |
| Q2 2022 | $3,691,000 | -38.5% | 757,848 | +13.3% | 0.94% | -51.6% |
| Q1 2022 | $6,002,000 | +123.0% | 669,100 | +179.9% | 1.95% | +35.3% |
| Q4 2021 | $2,692,000 | – | 239,041 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $180,267,308 | 53.77% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,504,317 | 38.83% |
| First Light Asset Management, LLC | 4,780,560 | $43,168,457 | 3.78% |
| Octagon Capital Advisors LP | 2,345,075 | $21,176,027 | 3.33% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $87,426,817 | 2.75% |
| TCG Crossover Management, LLC | 2,890,816 | $26,104,068 | 2.72% |
| 5AM Venture Management, LLC | 1,245,000 | $11,242,350 | 2.52% |
| Exome Asset Management LLC | 274,900 | $2,482,348 | 2.16% |
| EcoR1 Capital, LLC | 5,714,404 | $51,601,068 | 1.58% |
| Affinity Asset Advisors, LLC | 1,135,702 | $10,255,389 | 1.18% |